Castle Biosciences CEO Derek Maetzold disposes of USD 581,331 in common shares

Reuters2026/09/01 20:12

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Castle Biosciences CEO Derek J. Maetzold reported stock option exercise on Aug. 28, 2026 for 12,428 shares at USD 2.39.
He sold 11,472 shares at a weighted-average USD 33.14, leaving 22,435 shares held directly.
He also sold 956 shares at a weighted-average USD 33.88, reducing direct holdings to 21,479 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-059816), on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Castle Biosciences CEO Derek Maetzold disposes of USD 581,331 in common shares

You may also like

Crypto prices